APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microbiome CDMO

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Microbiome CDMO Industry Growth and Trends Forecast to 2032

1 January 2026112 pages

Choose your research edition.

Industry ResearchMicrobiome CDMO Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbiome CDMO Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Microbiome CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbiome CDMO Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Microbiome CDMO Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Microbiome CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Microbiome CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Microbiome CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbiome CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Microbiome CDMO market include Arranta Bio, Wacker Chemie AG, Bactera, SGS Quay Pharma, Biose, EnteroBiotix, Genome And Company, Lallemand Health Solutions and List Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Microbiome CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Microbiome CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Microbiome CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Microbiome CDMO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Microbiome CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Microbiome CDMO Market by Company

Arranta Bio

Wacker Chemie AG

Bactera

SGS Quay Pharma

Biose

EnteroBiotix

Genome And Company

Lallemand Health Solutions

List Bio

Rise BioServices

Lonza

MaaT Pharma

NIZO

Quay Pharmaceuticals

Recipharm

Microbiome CDMO Segment by Type

Microbial CDMO

Antibiotic CDMO

Phage CDMO

Bacteriocins CDMO

Microbiome CDMO Segment by Application

Vaccine R&D

Biopharmaceutical

Cell Therapy

Others

Microbiome CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiome CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbiome CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiome CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Microbiome CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Microbiome CDMO Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Microbiome CDMO Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Microbiome CDMO Market Share by Region (2021-2026) Table 4. Global Microbiome CDMO Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Microbiome CDMO Market Share by Region (2027-2032) Table 6. Global Microbiome CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Microbiome CDMO Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Microbiome CDMO Market Size Share by Type (2021-2026) Table 9. Global Microbiome CDMO Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Microbiome CDMO Market Size Share Forecasted by Type (2027-2032) Table 11. North America Microbiome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Microbiome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Microbiome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Microbiome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Microbiome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Microbiome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Microbiome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Microbiome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Microbiome CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Microbiome CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Microbiome CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Microbiome CDMO Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Microbiome CDMO Market Size Share by Application (2021-2026) Table 24. Global Microbiome CDMO Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Microbiome CDMO Market Size Share Forecasted by Application (2027-2032) Table 26. North America Microbiome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Microbiome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Microbiome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Microbiome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Microbiome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Microbiome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Microbiome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Microbiome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Microbiome CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Microbiome CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Microbiome CDMO Industry Trends Table 37. Microbiome CDMO Industry Drivers Table 38. Microbiome CDMO Industry Opportunities and Challenges Table 39. Microbiome CDMO Industry Restraints Table 40. Global Microbiome CDMO Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Microbiome CDMO Revenue Market Share by Company (2021-2026) Table 42. Global Microbiome CDMO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Microbiome CDMO Key Company Headquarters & Area Served Table 44. Global Microbiome CDMO Company, Product Type & Application Table 45. Global Microbiome CDMO Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Microbiome CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Arranta Bio Company Information Table 49. Arranta Bio Business Overview Table 50. Arranta Bio Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Arranta Bio Microbiome CDMO Product Portfolio Table 52. Arranta Bio Recent Development Table 53. Wacker Chemie AG Company Information Table 54. Wacker Chemie AG Business Overview Table 55. Wacker Chemie AG Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Wacker Chemie AG Microbiome CDMO Product Portfolio Table 57. Wacker Chemie AG Recent Development Table 58. Bactera Company Information Table 59. Bactera Business Overview Table 60. Bactera Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bactera Microbiome CDMO Product Portfolio Table 62. Bactera Recent Development Table 63. SGS Quay Pharma Company Information Table 64. SGS Quay Pharma Business Overview Table 65. SGS Quay Pharma Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. SGS Quay Pharma Microbiome CDMO Product Portfolio Table 67. SGS Quay Pharma Recent Development Table 68. Biose Company Information Table 69. Biose Business Overview Table 70. Biose Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Biose Microbiome CDMO Product Portfolio Table 72. Biose Recent Development Table 73. EnteroBiotix Company Information Table 74. EnteroBiotix Business Overview Table 75. EnteroBiotix Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. EnteroBiotix Microbiome CDMO Product Portfolio Table 77. EnteroBiotix Recent Development Table 78. Genome And Company Company Information Table 79. Genome And Company Business Overview Table 80. Genome And Company Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Genome And Company Microbiome CDMO Product Portfolio Table 82. Genome And Company Recent Development Table 83. Lallemand Health Solutions Company Information Table 84. Lallemand Health Solutions Business Overview Table 85. Lallemand Health Solutions Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Lallemand Health Solutions Microbiome CDMO Product Portfolio Table 87. Lallemand Health Solutions Recent Development Table 88. List Bio Company Information Table 89. List Bio Business Overview Table 90. List Bio Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. List Bio Microbiome CDMO Product Portfolio Table 92. List Bio Recent Development Table 93. Rise BioServices Company Information Table 94. Rise BioServices Business Overview Table 95. Rise BioServices Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Rise BioServices Microbiome CDMO Product Portfolio Table 97. Rise BioServices Recent Development Table 98. Lonza Company Information Table 99. Lonza Business Overview Table 100. Lonza Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Lonza Microbiome CDMO Product Portfolio Table 102. Lonza Recent Development Table 103. MaaT Pharma Company Information Table 104. MaaT Pharma Business Overview Table 105. MaaT Pharma Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. MaaT Pharma Microbiome CDMO Product Portfolio Table 107. MaaT Pharma Recent Development Table 108. NIZO Company Information Table 109. NIZO Business Overview Table 110. NIZO Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. NIZO Microbiome CDMO Product Portfolio Table 112. NIZO Recent Development Table 113. Quay Pharmaceuticals Company Information Table 114. Quay Pharmaceuticals Business Overview Table 115. Quay Pharmaceuticals Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Quay Pharmaceuticals Microbiome CDMO Product Portfolio Table 117. Quay Pharmaceuticals Recent Development Table 118. Recipharm Company Information Table 119. Recipharm Business Overview Table 120. Recipharm Microbiome CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Recipharm Microbiome CDMO Product Portfolio Table 122. Recipharm Recent Development Table 123. North America Microbiome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Microbiome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Microbiome CDMO Market Share by Country (2021-2026) Table 126. North America Microbiome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Microbiome CDMO Market Share Forecast by Country (2027-2032) Table 128. Europe Microbiome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Microbiome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Microbiome CDMO Market Share by Country (2021-2026) Table 131. Europe Microbiome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Microbiome CDMO Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Microbiome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Microbiome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Microbiome CDMO Market Share by Country (2021-2026) Table 136. Asia-Pacific Microbiome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Microbiome CDMO Market Share Forecast by Country (2027-2032) Table 138. Latin America Microbiome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Microbiome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Microbiome CDMO Market Share by Country (2021-2026) Table 141. Latin America Microbiome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Microbiome CDMO Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Microbiome CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Microbiome CDMO Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Microbiome CDMO Market Share by Country (2021-2026) Table 146. Middle East & Africa Microbiome CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Microbiome CDMO Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Microbiome CDMO Product Image Figure 3. Global Microbiome CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Microbiome CDMO Market Size (2021-2032) & (US$ Million) Figure 5. Global Microbiome CDMO Market Share by Region: 2025 VS 2032 Figure 6. Global Microbiome CDMO Market Share by Region (2021-2032) Figure 7. North America Microbiome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Microbiome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Microbiome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Microbiome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Microbiome CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Microbial CDMO Image Figure 13. Global Microbial CDMO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Antibiotic CDMO Image Figure 15. Global Antibiotic CDMO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Phage CDMO Image Figure 17. Global Phage CDMO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Bacteriocins CDMO Image Figure 19. Global Bacteriocins CDMO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Microbiome CDMO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Microbiome CDMO Market Share by Type 2025 VS 2032 Figure 22. North America Microbiome CDMO Market Size Share by Type (2021-2032) Figure 23. Europe Microbiome CDMO Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Microbiome CDMO Market Size Share by Type (2021-2032) Figure 25. Latin America Microbiome CDMO Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Microbiome CDMO Market Size Share by Type (2021-2032) Figure 27. Vaccine R&D Image Figure 28. Global Vaccine R&D Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Biopharmaceutical Image Figure 30. Global Biopharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Cell Therapy Image Figure 32. Global Cell Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Microbiome CDMO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Microbiome CDMO Market Share by Application 2025 VS 2032 Figure 37. North America Microbiome CDMO Market Size Share by Application (2021-2032) Figure 38. Europe Microbiome CDMO Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Microbiome CDMO Market Size Share by Application (2021-2032) Figure 40. Latin America Microbiome CDMO Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Microbiome CDMO Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Microbiome CDMO Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Microbiome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Microbiome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Microbiome CDMO Market Share by Country (2021-2032) Figure 47. Europe Microbiome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Microbiome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Microbiome CDMO Market Share by Country (2021-2032) Figure 50. Asia-Pacific Microbiome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Microbiome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Microbiome CDMO Market Share by Country (2021-2032) Figure 53. Latin America Microbiome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Microbiome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Microbiome CDMO Market Share by Country (2021-2032) Figure 56. Middle East & Africa Microbiome CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Microbiome CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Microbiome CDMO Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Microbial CDMO
  • Antibiotic CDMO
  • Phage CDMO
  • Bacteriocins CDMO
Applications
  • Vaccine R&D
  • Biopharmaceutical
  • Cell Therapy
  • Others
Companies covered
  • Arranta Bio
  • Wacker Chemie AG
  • Bactera
  • SGS Quay Pharma
  • Biose
  • EnteroBiotix
  • Genome And Company
  • Lallemand Health Solutions
  • List Bio
  • Rise BioServices
  • Lonza
  • MaaT Pharma
  • NIZO
  • Quay Pharmaceuticals
  • Recipharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Microbiome CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Microbiome CDMO Market Size by Region (2021-2032)
  5. 1.4.1 Global Microbiome CDMO Market Size by Region (2021-2026)
  6. 1.4.2 Global Microbiome CDMO Market Size by Region (2027-2032)
  7. 1.5 Key Regions Microbiome CDMO Market Size (2021-2032)
  8. 1.5.1 North America Microbiome CDMO Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Microbiome CDMO Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Microbiome CDMO Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Microbiome CDMO Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Microbiome CDMO Market Size Growth Rate (2021-2032)
2 Microbiome CDMO Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Microbial CDMO
  3. 2.1.2 Antibiotic CDMO
  4. 2.1.3 Phage CDMO
  5. 2.1.4 Bacteriocins CDMO
  6. 2.2 Global Microbiome CDMO Market Size by Type
  7. 2.2.1 Global Microbiome CDMO Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Microbiome CDMO Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Microbiome CDMO Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Microbiome CDMO Market Size by Regions
  11. 2.3.1 North America Microbiome CDMO Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Microbiome CDMO Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Microbiome CDMO Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Microbiome CDMO Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Microbiome CDMO Market Size Breakdown by Type (2021-2026)
3 Microbiome CDMO Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Vaccine R&D
  3. 3.1.2 Biopharmaceutical
  4. 3.1.3 Cell Therapy
  5. 3.1.4 Others
  6. 3.2 Global Microbiome CDMO Market Size by Application
  7. 3.2.1 Global Microbiome CDMO Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Microbiome CDMO Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Microbiome CDMO Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Microbiome CDMO Market Size by Regions
  11. 3.3.1 North America Microbiome CDMO Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Microbiome CDMO Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Microbiome CDMO Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Microbiome CDMO Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Microbiome CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Microbiome CDMO Industry Trends
  2. 4.2 Microbiome CDMO Industry Drivers
  3. 4.3 Microbiome CDMO Industry Opportunities and Challenges
  4. 4.4 Microbiome CDMO Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Microbiome CDMO Revenue (2021-2026)
  2. 5.2 Global Microbiome CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Microbiome CDMO Key Company Headquarters & Area Served
  4. 5.4 Global Microbiome CDMO Company, Product Type & Application
  5. 5.5 Global Microbiome CDMO Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Microbiome CDMO Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Microbiome CDMO Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Microbiome CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Arranta Bio
  2. 6.1.1 Arranta Bio Company Information
  3. 6.1.2 Arranta Bio Business Overview
  4. 6.1.3 Arranta Bio Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Arranta Bio Microbiome CDMO Product Portfolio
  6. 6.1.5 Arranta Bio Recent Developments
  7. 6.2 Wacker Chemie AG
  8. 6.2.1 Wacker Chemie AG Company Information
  9. 6.2.2 Wacker Chemie AG Business Overview
  10. 6.2.3 Wacker Chemie AG Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Wacker Chemie AG Microbiome CDMO Product Portfolio
  12. 6.2.5 Wacker Chemie AG Recent Developments
  13. 6.3 Bactera
  14. 6.3.1 Bactera Company Information
  15. 6.3.2 Bactera Business Overview
  16. 6.3.3 Bactera Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bactera Microbiome CDMO Product Portfolio
  18. 6.3.5 Bactera Recent Developments
  19. 6.4 SGS Quay Pharma
  20. 6.4.1 SGS Quay Pharma Company Information
  21. 6.4.2 SGS Quay Pharma Business Overview
  22. 6.4.3 SGS Quay Pharma Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 SGS Quay Pharma Microbiome CDMO Product Portfolio
  24. 6.4.5 SGS Quay Pharma Recent Developments
  25. 6.5 Biose
  26. 6.5.1 Biose Company Information
  27. 6.5.2 Biose Business Overview
  28. 6.5.3 Biose Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Biose Microbiome CDMO Product Portfolio
  30. 6.5.5 Biose Recent Developments
  31. 6.6 EnteroBiotix
  32. 6.6.1 EnteroBiotix Company Information
  33. 6.6.2 EnteroBiotix Business Overview
  34. 6.6.3 EnteroBiotix Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 EnteroBiotix Microbiome CDMO Product Portfolio
  36. 6.6.5 EnteroBiotix Recent Developments
  37. 6.7 Genome And Company
  38. 6.7.1 Genome And Company Company Information
  39. 6.7.2 Genome And Company Business Overview
  40. 6.7.3 Genome And Company Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Genome And Company Microbiome CDMO Product Portfolio
  42. 6.7.5 Genome And Company Recent Developments
  43. 6.8 Lallemand Health Solutions
  44. 6.8.1 Lallemand Health Solutions Company Information
  45. 6.8.2 Lallemand Health Solutions Business Overview
  46. 6.8.3 Lallemand Health Solutions Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Lallemand Health Solutions Microbiome CDMO Product Portfolio
  48. 6.8.5 Lallemand Health Solutions Recent Developments
  49. 6.9 List Bio
  50. 6.9.1 List Bio Company Information
  51. 6.9.2 List Bio Business Overview
  52. 6.9.3 List Bio Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 List Bio Microbiome CDMO Product Portfolio
  54. 6.9.5 List Bio Recent Developments
  55. 6.10 Rise BioServices
  56. 6.10.1 Rise BioServices Company Information
  57. 6.10.2 Rise BioServices Business Overview
  58. 6.10.3 Rise BioServices Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Rise BioServices Microbiome CDMO Product Portfolio
  60. 6.10.5 Rise BioServices Recent Developments
  61. 6.11 Lonza
  62. 6.11.1 Lonza Company Information
  63. 6.11.2 Lonza Business Overview
  64. 6.11.3 Lonza Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Lonza Microbiome CDMO Product Portfolio
  66. 6.11.5 Lonza Recent Developments
  67. 6.12 MaaT Pharma
  68. 6.12.1 MaaT Pharma Company Information
  69. 6.12.2 MaaT Pharma Business Overview
  70. 6.12.3 MaaT Pharma Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 MaaT Pharma Microbiome CDMO Product Portfolio
  72. 6.12.5 MaaT Pharma Recent Developments
  73. 6.13 NIZO
  74. 6.13.1 NIZO Company Information
  75. 6.13.2 NIZO Business Overview
  76. 6.13.3 NIZO Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 NIZO Microbiome CDMO Product Portfolio
  78. 6.13.5 NIZO Recent Developments
  79. 6.14 Quay Pharmaceuticals
  80. 6.14.1 Quay Pharmaceuticals Company Information
  81. 6.14.2 Quay Pharmaceuticals Business Overview
  82. 6.14.3 Quay Pharmaceuticals Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Quay Pharmaceuticals Microbiome CDMO Product Portfolio
  84. 6.14.5 Quay Pharmaceuticals Recent Developments
  85. 6.15 Recipharm
  86. 6.15.1 Recipharm Company Information
  87. 6.15.2 Recipharm Business Overview
  88. 6.15.3 Recipharm Microbiome CDMO Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Recipharm Microbiome CDMO Product Portfolio
  90. 6.15.5 Recipharm Recent Developments
7 North America
  1. 7.1 North America Microbiome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Microbiome CDMO Market Size by Country (2021-2026)
  3. 7.3 North America Microbiome CDMO Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Microbiome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Microbiome CDMO Market Size by Country (2021-2026)
  3. 8.3 Europe Microbiome CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Microbiome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Microbiome CDMO Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Microbiome CDMO Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Microbiome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Microbiome CDMO Market Size by Country (2021-2026)
  3. 10.3 South America Microbiome CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Microbiome CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Microbiome CDMO Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Microbiome CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst